Subscribe To
Allergy therapeutics doses first patients with peanut allergy vaccine
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF), the commercial-stage biotech company, has started admin...
March 27, 2023, 2:36 am
3 tech stocks to buy for the fourth industrial revolution
The Fourth Industrial Revolution refers to the use of multiple advanced technologies, including “artificial intelligence (AI), robotics, [and] the ...
March 25, 2023, 9:44 am
Could this stock become the tesla of its industry?
CRISPR's gene editing process could change how we treat disease. The biotech's first potential product, exa-cel, could soon hit the market....
March 25, 2023, 9:30 am
Xbi: underperformance of small cap biotech likely to continue
XBI sits 58% below its all-time high. Yet I still don't think it is a good investment here. There are too many risk factors for the smaller ...
March 25, 2023, 8:41 am
4d molecular therapeutics: promising preliminary safety and efficacy for 4d-310
With its strong focus on product design and development excellence, as evidenced by its sustained success in IND clearance, 4D Molecular Therapeutics ...
March 25, 2023, 1:38 am
Iovance biotherapeutics completes license application submission for advanced melanoma therapy; shares rally
biotech cancer-treatment developer Iovance Biotherapeutics Inc. IOVA, -3.83% on Friday said it had comp...
March 24, 2023, 7:55 pm
Bio-path holdings to announce fourth quarter and full year 2022 financial results on march 31, 2023
HOUSTON, March 24, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® ant...
March 24, 2023, 4:01 pm
biotech growth stock soars to new highs on lung disease breakthrough
Regeneron is scaling new highs after a lung disease breakthrough and analyst upgrade. The post biotech ...
March 24, 2023, 2:17 pm
The cream of the crop: 5 biotech stocks that outrank 91% of all stocks
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising ...
March 24, 2023, 12:33 pm
Carl icahn claims illumina directors got extra insurance to close 'disastrous' $7.1 billion grail deal
Carl Icahn claims Illumina directors demanded extra personal liability insurance before the biotech com...
March 24, 2023, 12:20 pm
Bay area tech and biotech layoffs worsen, microsoft slashes more jobs
Tech and biotech layoffs have worsened in the Bay Area, a fresh round of cutbacks resulting from job cu...
March 23, 2023, 1:00 pm
Why moderna wants to raise the cost of its covid-19 vaccine
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss key takeaways from Moderna CEO Stéphane Bancel's testimony before the Senate and why ...
March 23, 2023, 12:00 pm
Sanofi's blockbuster dupixent drug clears major trial
French pharma multinational Sanofi's Dupixent drug has achieved impressive results in a late-stage trial to treat chronic obstructive pulmonary diseas...
March 23, 2023, 10:43 am
Zura stock alert: zura bio spac merger rally ends
Zura Bio (NASDAQ: ZURA ) stock is on the move Thursday following the clinical-stage biotechnology company's recent public debut. Zura Bio went public ...
March 23, 2023, 10:15 am
Nautilus biotechnology to participate in b. riley securities' disruptive biotech enabling technologies – proteomics, virtual conference
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule pro...
March 23, 2023, 8:00 am
This is my highest-conviction stock to own in 2023 and beyond
Vertex Pharmaceuticals' business is insulated from the effects of economic cycles. The biotech's history of innovation continues, and it's aiming to d...
March 23, 2023, 7:45 am
Is ishares biotechnology etf (ibb) a strong etf right now?
Smart Beta ETF report for IBB...
March 23, 2023, 7:36 am
Seagen founder clay siegall is back in biotech as ceo of purdue university spinout
Clay Siegall, the Seagen founder who resigned last year following an arrest and allegations of domestic violence, is jumping back into the ...
March 22, 2023, 7:16 pm
Biogen als drug considered not effective by fda advisory panel
Biogen Inc. BIIB, -1.85% received a setback late Wednesday after a Food and Drug Administration advisory committee said the ...
March 22, 2023, 6:27 pm
Gracell biotechnologies to participate in two upcoming investor conferences
SAN DIEGO and SUZHOU, China and SHANGHAI, China, March 22, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ:...
March 22, 2023, 4:10 pm